NCT03963947View on ClinicalTrials.gov

Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With House Dust Mites

CompletedOBSERVATIONAL
Enrollment

97

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

May 24, 2023

Study Completion Date

May 24, 2023

Conditions
Rhinoconjunctivitis With or Without Allergic Asthma
Interventions
BIOLOGICAL

Beltavac® Polymerized with house dust mites

Adminstration of Beltavac® Polymerized with house dust mites according to the routine clinical practice

Trial Locations (1)

Unknown

Teknon Medical Center, Barcelona

All Listed Sponsors
collaborator

Probelte Pharma S.L.U.

INDUSTRY

lead

Alfons Malet i Casajuana

OTHER

NCT03963947 - Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With House Dust Mites | Biotech Hunter | Biotech Hunter